News
Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) ...
Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug ...
5h
TipRanks on MSNAllarity Therapeutics Launches Phase 2 Trial for StenoparibAllarity Therapeutics ( ($ALLR) ) has shared an update. On June 2, 2025, Allarity Therapeutics announced the enrollment of the first patient in ...
Results, presented simultaneously in oral presentation at ASCO 2025 and in peer-reviewed Gynecologic Oncology, suggest very meaningful survival effect of IMNN-001 in women HRP and HRD positive, ...
Home > Press release: Successful Development of Innovative and ...
To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results